Bergen 9 November 2021

Reference is made to the announcement published on 5 October 2021 by Lifecare AS
(the "Company") regarding the issue of 15,467,834 new shares upon completion of
a private placement of shares.

The share capital increase pertaining to the issuance of new shares under the
private placement has now been registered with the Norwegian Register of
Business Enterprises. The Company's new registered share capital is NOK
39,193,658.8 divided into 97,984,147 shares, each with a par value of NOK 0.4.

This is Lifecare
Lifecare is a Bergen-based technology company developing a miniaturized
implantable long-term sensor for correct and continuous monitoring of blood
sugar in people with diabetes. The Company's patented technology also has the
potential for use in various biomarkers. Lifecare AS is listed on Euronext
Growth (LIFE).

For further information, please contact:
Joacim Holter, CEO, Lifecare AS,  joacim.holter@lifecare.no, +47 40 05 90 40

This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.This stock exchange announcement
was published by Kine Hereid, Investor Relations at Lifecare AS, on 09.11.2021
at 09.00 CET.